Advanced search
Publication Cover
Acta Cardiologica Volume 73, 2018 - Issue 6
Submit an article Journal homepage
179
Views
2
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Prevention of minor myocardial injury after elective percutaneous coronary intervention: comparison of ticagrelor versus clopidogrel

Hüseyin GöksülükCardiology Department, Ankara University, Ankara, TurkeyCorrespondence[email protected]
,
Yusuf AtmacaCardiology Department, Ankara University, Ankara, Turkey
,
Menekşe Gerede UludağCardiology Department, Ankara University, Ankara, Turkey
,
Cansın Tulunay KayaCardiology Department, Ankara University, Ankara, Turkey
,
Onur YıldırımCardiology Department, Ankara University, Ankara, Turkey
,
Müge AkbulutCardiology Department, Ankara University, Ankara, Turkey
,
Nil ÖzyüncüCardiology Department, Ankara University, Ankara, Turkey
&
Cetin ErolCardiology Department, Ankara University, Ankara, Turkey
 show all
Pages 584-590 | Received 11 Nov 2017, Accepted 15 Jan 2018, Published online: 22 Jan 2018

References

  • Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998; 31:241–251.
  • Klein LW, Kramer BL, Howard E, et al. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q-wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 1991; 17:621–626.
  • Oh JK, Shub C, Ilstrup DM, et al. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 1985; 109:1225–1231.
  • Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol. 1999; 33:88–96.
  • Simoons ML, Van den Brand M, Lincoff M, et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J. 1999; 20:1112–1119.
  • Herrmann J, von Birgelen C, Haude M, et al. Prognostic implication of cardiac troponin T increase following stent implantation. Heart. 2002; 87:549–553.
  • Prasad A, Singh M, Lerman A, et al. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol. 2006; 48:1765–1770.
  • Nallamothu BK, Chetcuti S, Mukherjee D, et al. Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol. 2003; 91:1272–1274.
  • Gómez JA, Cequier A, Valero J, et al. Minor myocardial damage during percutaneous coronary intervention does not affect long-term prognosis. Rev Esp Cardiol. 2009; 62:625–632.
  • Kapoor JR. Platelet activation and atherothrombosis. N Engl J Med. 2008; 358:1638.
  • Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005; 352:1179–1189.
  • Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357:2001–2015.
  • Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361:1045–1057.
  • Steg G, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33:2569–2619.
  • Roffi M, Patrono C, Collet JP, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016; 37:267–315.
  • Bonaca MP, Bhatt DL, Cohen M, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015; 372:1791–1800.
  • Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Glob Heart. 2012; 7:275–295.
  • Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 1996; 334:1084–1089.
  • Perry CG, Shuldiner AR. Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation?. J Hum Genet. 2013; 58:339–345.
  • Esposito G. Responsiveness to P2Y12 receptor inhibitors. Curr Opin Cardiol. 2011; 26:S31–S37.
  • Piccolo R, Di Gioia G, Niglio T, et al. Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome. Angiology. 2014; 65:130–136.
  • Husted S, Emanuelsson H, Heptinstall S, et al. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in the patients with atherosclerosis: a duble-blinde comparision to clopidogrel with aspirin. Eur Heart J. 2006;27:1038–1047.
  • Abbas SA, Glazier JJ, Dupont C, et al. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty. Clin Cardiol. 1996; 19:782–786.
  • Cantor WJ, Newby K, Chistenson RH, SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators, et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol. 2002;39:1738–1744.
  • Brener SJ, Ellis SG, Schneider J, et al. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J. 2002; 23:869–876.
  • Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. J Am Coll Cardiol. 1999; 34:663–671.
  • Cavallini C, Savonitto S, Violini R, et al. Impact of the evaluation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J. 2005; 26:1506–1512.
  • Kini A, Lee P, Marmur JD, et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting midterm mortality. Am J Cardiol. 2004; 93:18–23.
  • Bertinchant JP, Polge A, Ledermann B, et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol. 1999; 84:51–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.